Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07256145

Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.

Detailed description

The current study will be conducted as a single-blinded prospective randomized controlled study to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia. All patients will be evaluated by: * Full history taking: including age, sex, presence of co-morbid conditions as well as the presenting complaint. * Clinical examination and routine lab investigations that include: * Complete blood count (CBC). * Fasting blood glucose (FBG). * Coagulation profile (bleeding time, prothrombin time, prothrombin activity, international normalized ratio). Measurements: Patients will be followed up at 24 hours, 1 week, and 6 weeks after injection. The following measurements will be recorded: 1. Pain will be assessed pre- and post-injection using VAS score at 24 hours, 1 week, and 6 weeks post-injection. 2. Need for analgesic intake post-injection will be assessed at the follow-up periods. 3. Patient satisfaction using the SAPS score. 4. Complications post-injection as pain, irritation or infection will be assessed.

Conditions

Interventions

TypeNameDescription
PROCEDUREerector spinae plane blockerector spinae plane block with steroids

Timeline

Start date
2025-08-01
Primary completion
2026-02-01
Completion
2026-03-01
First posted
2025-12-01
Last updated
2025-12-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07256145. Inclusion in this directory is not an endorsement.